Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A few starter tips for newcomers to zero based budgeting, focusing on setup, tracking, and simple adjustments.
16,063 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
The SEC's updated listing standards could cut the time to a Cardano spot ETF dramatically, using CME Group's Cardano ...
Plug Power stock popped after-hours following a strong Q4 showing and raised 2026 guidance. This article breaks down ...
When a stock leads the market after a big index move, investors pay attention. This piece explains why Argan stock to...
Quantum computing promises a new tech frontier, but today's stock prices often reflect dreams more than cash flow. Th...
Investors eyes are on Hackett Group as 2026 unfolds. This guide breaks down how to read the Hackett Group (HCKT) 2026...
As AI reshapes markets, Palantir’s unique software moat could ignite a new chapter in growth. This guide compares Pal...
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...
A proposed social media tax in Illinois has critics calling it illinois’ social media shambles. This in-depth look ex...
Stock splits grab headlines, but they don’t change a company’s fundamentals. This guide untangles why wall street's l...
A stock dip can be a doorway to opportunity if you approach it with a solid plan. This guide explains how to evaluate...